Industry: Healthcare Region: United States Transaction Price: USD 1 million Transaction Method: Equity investment
Project Introduction:
Founded in 2000, the company is involved in many key areas of biohealth, such as biosensors, microbial threats, food safety, and has an experienced operation management and R&D technical team.
Its newly launched PCR polynucleic acid rapid detection all-in-one machine, mainly for respiratory viruses and s-exually trans-mitted diseases, can detect samples more abundant and more compatible than other product types on the market. Up to eight pathogens can be tested for simultaneously in symptomatic patients. No calibration required, stable at room temperature. Occupy s-mall space, can move. The whole process is automatic, real-time detection results in 1 hour, without trained medical personnel operation. The cloud link system supports real-time data sharing, and can realize remote technical support, system update, virus database expansion and other functions.
It is suitable for grassroots medical institutions that ha-ve the need of rapid multi-virus detection and diagnosis but do not ha-ve their own central testing laboratory, such as women's and children's hospitals, infectious disease prevention and control points, community hospitals, etc.
Cooperation mode:
Hope to look for partners in China to jointly register products in China and expand the Chinese market.